| SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets S Zheng, W Wang, J Aldahdooh, A Malyutina, T Shadbahr, Z Tanoli, ... Genomics, Proteomics and Bioinformatics 20 (3), 587-596, 2022 | 250 | 2022 |
| DrugComb: an integrative cancer drug combination data portal B Zagidullin, J Aldahdooh, S Zheng, W Wang, Y Wang, J Saad, ... Nucleic acids research 47 (W1), W43-W51, 2019 | 178 | 2019 |
| DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal S Zheng, J Aldahdooh, T Shadbahr, Y Wang, D Aldahdooh, J Bao, ... Nucleic acids research 49 (W1), W174-W184, 2021 | 78 | 2021 |
| RNA atlas of human bacterial pathogens uncovers stress dynamics linked to infection K Avican, J Aldahdooh, M Togninalli, AKMF Mahmud, J Tang, ... Nature communications 12 (1), 3282, 2021 | 41 | 2021 |
| UNaProd: A Universal Natural Product Database for Materia Medica of Iranian Traditional Medicine A Naghizadeh, D Hamzeheian, S Akbari, F Mohammadi, T Otoufat, ... Evidence‐Based Complementary and Alternative Medicine 2020 (1), 3690781, 2020 | 19 | 2020 |
| DrugRepo: a novel approach to repurposing drugs based on chemical and genomic features Y Wang, J Aldahdooh, Y Hu, H Yang, M Vähä-Koskela, J Tang, Z Tanoli Scientific Reports 12 (1), 21116, 2022 | 13 | 2022 |
| Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments Z Tanoli, J Aldahdooh, F Alam, Y Wang, U Seemab, M Fratelli, P Pavlis, ... Briefings in Bioinformatics 23 (1), bbab350, 2022 | 11 | 2022 |
| Using BERT to identify drug-target interactions from whole PubMed J Aldahdooh, M Vähä-Koskela, J Tang, Z Tanoli BMC bioinformatics 23 (1), 245, 2022 | 10 | 2022 |
| Can we assume the gene expression profile as a proxy for signaling network activity? M Piran, R Karbalaei, M Piran, J Aldahdooh, M Mirzaie, N Ansari-Pour, ... Biomolecules 10 (6), 850, 2020 | 8 | 2020 |
| SynergyFinder Plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteomics Bioinform S Zheng, W Wang, J Aldahdooh, A Malyutina, T Shadbahr, Z Tanoli | 7 | 2022 |
| R-BERT-CNN: Drug-target interactions extraction from biomedical literature J Aldahdooh, Z Tanoli, J Tang Proceedings of the seventh BioCreative challenge evaluation workshop, 2021 | 6 | 2021 |
| SynergyFinder Plus: Towards a Better Interpretation and Annotation of Drug Combination Screening Datasets. bioRxiv 2021 S Zheng, W Wang, J Aldahdooh, A Malyutina, T Shadbahr, A Pessia, ... CrossRef][PubMed], 0 | 5 | |
| Investigating the importance of meta-features for classification tasks in meta-learning T Horvath, JM Aldahdooh Eötvös Lorand University Faculty of Informatics, 1-66, 2017 | 2 | 2017 |
| Mining drug-target interactions from biomedical literature using chemical and gene descriptions-based ensemble transformer model J Aldahdooh, Z Tanoli, J Tang bioRxiv, 2023.07. 24.550359, 2023 | 1 | 2023 |
| Enhancing the Lifetime of WSN Using a Modified Ant Colony Optimization Algorithm BK Elfarra, MA Salha, RS Rasheed, J Aldahdooh, AA AbuSamra | 1 | 2023 |
| A gene essentiality signature for studying the mechanism of action of drugs W Wang, J Bao, S Zheng, S Huang, J Aldahdooh, Y Wang, J Eriksson, ... bioRxiv, 2022.11. 07.514541, 2022 | 1 | 2022 |
| Building a comprehensive drug-target knowledge base using biomedical text mining J Aldahdooh Helsingin yliopisto, 2024 | | 2024 |
| Traffic Congestion Prevention Using Ant Colony Optimization A AbuSamra, A Ashour, M Ghazal, J Aldahdooh, R Abuarja 2023 8th International Engineering Conference on Renewable Energy …, 2023 | | 2023 |
| A gene essentiality signature enables predicting the mechanism of action of drugs W Wang, J Bao, S Zheng, S Huang, J Aldahdooh, Y Wang, J Eriksson, ... | | 2022 |
| 2022-RA-961-ESGO Real-world prospective characterization of homologous recombination deficiency in advanced ovarian cancer M Salko, F Perez-Villatoro, J Aldahdooh, A Chernenko, E Pietilä, ... International Journal of Gynecologic Cancer 32 (Suppl 2), 2022 | | 2022 |
Jing TangAssociate professor, University of Helsinki在 helsinki.fi 的电子邮件经过验证
